Title : Pharmacology, safety, efficacy and clinical uses of the COX-2 inhibitor robenacoxib.

Pub. Date : 2022 Apr 22

PMID : 35460083






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 At registered dosages (2 mg/kg subcutaneously in dogs and cats, 1-4 mg/kg orally in dogs and 1-2.4 mg/kg orally in cats), robenacoxib produces significant inhibition of COX-2 whilst sparing COX-1. robenacoxib cytochrome c oxidase subunit II Felis catus